dermatology

News

a person's arm with skin lesion triaging tool against the skin

Skin Analytics' dermatology AI backed for NHS use

An AI-powered tool for triaging patients with suspicious skin lesions, developed by Skin Analytics, will be used by the NHS to reduce waiting times.

News

J&J shows its confidence in oral IL-23 drug for psoriasis

J&J wants to turn the screw in the psoriasis market with a new head-to-head trial pitting oral IL-23 drug icotrokinra against Stelara.

News

AstraZeneca builds in China as Cosette buys Mayne

The reporting week has ended with a flurry of M&A as Cosette Pharma and AstraZeneca agree takeover deals.

News

Galderma adds new indication for blockbuster hope Nemluvio

Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to its label.

News

J&J plots filings after psoriasis drug clears phase 3 test

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial.

News

Rosacea case showing redness and inflammatory papules and pustules

Journey slips on FDA approval of rosacea therapy

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care" drug for the common skin disorder.

Skin Analytics' dermatology AI backed for NHS use

J&J shows its confidence in oral IL-23 drug for psoriasis

AstraZeneca builds in China as Cosette buys Mayne

Galderma adds new indication for blockbuster hope Nemluvio

J&J plots filings after psoriasis drug clears phase 3 test

Journey slips on FDA approval of rosacea therapy

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

dermatology

Editor's Picks